Silke Baasner
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Click Chemistry and Applications
- Synthesis and Catalytic Reactions
- Asymmetric Synthesis and Catalysis
Papers in
-
- Synthesis and biological activity 9
- Synthesis and Biological Evaluation 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- E Günther (9 shared papers)Thomas Beckers (3 shared papers)Matthias Gerlach (7 shared papers)Péter Schmidt (7 shared papers)Eberhard Unger (5 shared papers)Klaus Müller (5 shared papers)Konrad J. Böhm (5 shared papers)Helge Prinz (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)Archiv der Pharmazie (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Silke Baasner
15 papers receiving 415 citations
Peers
Comparison fields: 5 of 61
- Toxicology 35
- Organic Chemistry 258
- Oncology 65
- Critical Care and Intensive Care Medicine 10
- Pharmacology 35
Countries citing papers authored by Silke Baasner
This map shows the geographic impact of Silke Baasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Baasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Baasner more than expected).
Fields of papers citing papers by Silke Baasner
This network shows the impact of papers produced by Silke Baasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Baasner. The network helps show where Silke Baasner may publish in the future.
Co-authors
The 25 scholars most cited alongside Silke Baasner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 93 | |
| 2 | 2002 | 72 | |
| 3 | 2007 | 47 | |
| 4 | 2017 | 30 | |
| 5 | 2009 | 26 | |
| 6 | Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase. | 1996 | 26 |
| 7 | 2006 | 23 | |
| 8 | 2010 | 22 | |
| 9 | 2013 | 21 | |
| 10 | 2009 | 20 | |
| 11 | 2016 | 17 | |
| 12 | 2011 | 17 | |
| 13 | 2004 | 6 | |
| 14 | 2008 | 2 | |
| 15 | 4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization | 2004 | 1 |
About Silke Baasner
Silke Baasner is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Oncology and Toxicology, having authored 15 papers that have together received 423 indexed citations. Recurring topics across this work include Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Synthesis and Biological Evaluation (3 papers), Synthesis of Organic Compounds (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Toxicology (35 citations), Organic Chemistry (258 citations), Oncology (65 citations), Critical Care and Intensive Care Medicine (10 citations) and Pharmacology (35 citations). Silke Baasner has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include E Günther, Thomas Beckers, Matthias Gerlach, Péter Schmidt, Eberhard Unger, Klaus Müller, Konrad J. Böhm, Helge Prinz, Siavosh Mahboobi and Frank‐D. Böhmer. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry, Archiv der Pharmazie and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.